672 related articles for article (PubMed ID: 24034415)
1. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
[TBL] [Abstract][Full Text] [Related]
3. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
[TBL] [Abstract][Full Text] [Related]
4. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
Chan WK; Nik Mustapha NR; Mahadeva S
J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study.
Lupșor-Platon M; Feier D; Stefănescu H; Tamas A; Botan E; Sparchez Z; Maniu A; Badea R
J Gastrointestin Liver Dis; 2015 Mar; 24(1):35-42. PubMed ID: 25822432
[TBL] [Abstract][Full Text] [Related]
6. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
de Lédinghen V; Wong GL; Vergniol J; Chan HL; Hiriart JB; Chan AW; Chermak F; Choi PC; Foucher J; Chan CK; Merrouche W; Chim AM; Le Bail B; Wong VW
J Gastroenterol Hepatol; 2016 Apr; 31(4):848-55. PubMed ID: 26514665
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter.
Ferraioli G; Calcaterra V; Lissandrin R; Guazzotti M; Maiocchi L; Tinelli C; De Silvestri A; Regalbuto C; Pelizzo G; Larizza D; Filice C
BMC Gastroenterol; 2017 May; 17(1):61. PubMed ID: 28472948
[TBL] [Abstract][Full Text] [Related]
9. A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B.
Xu L; Lu W; Li P; Shen F; Mi YQ; Fan JG
Dig Liver Dis; 2017 Aug; 49(8):910-917. PubMed ID: 28433586
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis.
Ferraioli G; Tinelli C; De Silvestri A; Lissandrin R; Above E; Dellafiore C; Poma G; Di Gregorio M; Maiocchi L; Maserati R; Filice C
Liver Int; 2016 Dec; 36(12):1860-1866. PubMed ID: 27439331
[TBL] [Abstract][Full Text] [Related]
11. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients.
Shen F; Zheng RD; Mi YQ; Wang XY; Pan Q; Chen GY; Cao HX; Chen ML; Xu L; Chen JN; Cao Y; Zhang RN; Xu LM; Fan JG
World J Gastroenterol; 2014 Apr; 20(16):4702-11. PubMed ID: 24782622
[TBL] [Abstract][Full Text] [Related]
12. Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality.
Mendes LC; Ferreira PA; Miotto N; Zanaga L; Lazarini MS; Gonçales ESL; Pedro MN; Gonçales FL; Stucchi RSB; Vigani AG
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):959-966. PubMed ID: 29727388
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of the controlled attenuation parameter for detecting liver steatosis in health checkup examinees.
Kim JK; Lee KS; Choi JR; Chung HJ; Jung DH; Lee KA; Lee JI
Gut Liver; 2015 May; 9(3):405-10. PubMed ID: 25717046
[TBL] [Abstract][Full Text] [Related]
14. The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice.
Yen YH; Chen JF; Wu CK; Lin MT; Chang KC; Tseng PL; Tsai MC; Lin JT; Hu TH
J Formos Med Assoc; 2017 Nov; 116(11):852-861. PubMed ID: 28888355
[TBL] [Abstract][Full Text] [Related]
15. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.
de Lédinghen V; Vergniol J; Capdepont M; Chermak F; Hiriart JB; Cassinotto C; Merrouche W; Foucher J; Brigitte le B
J Hepatol; 2014 May; 60(5):1026-31. PubMed ID: 24378529
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography.
Yilmaz Y; Ergelen R; Akin H; Imeryuz N
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1330-4. PubMed ID: 23660937
[TBL] [Abstract][Full Text] [Related]
17. Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy.
Yilmaz Y; Yesil A; Gerin F; Ergelen R; Akin H; Celikel ÇA; Imeryuz N
Scand J Gastroenterol; 2014 May; 49(5):611-6. PubMed ID: 24611771
[TBL] [Abstract][Full Text] [Related]
18. Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population.
Hu R; Wu B; Wang C; Wu Z; Zhang X; Chen X; Lu G; Yuan K
Int J Surg; 2024 Apr; 110(4):2044-2054. PubMed ID: 38215263
[TBL] [Abstract][Full Text] [Related]
19. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.
Chon YE; Jung KS; Kim SU; Park JY; Park YN; Kim DY; Ahn SH; Chon CY; Lee HW; Park Y; Han KH
Liver Int; 2014 Jan; 34(1):102-9. PubMed ID: 24028214
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B.
Cardoso AC; Beaugrand M; de Ledinghen V; Douvin C; Poupon R; Trinchet JC; Ziol M; Bedossa P; Marcellin P
Ann Hepatol; 2015; 14(6):826-36. PubMed ID: 26436354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]